Mindfulness for Pain Management in Patients With Cancer

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT03351010
Collaborator
Ministry of Health, Thailand (Other)
17
1
2
10.3
1.7

Study Details

Study Description

Brief Summary

Using pharmacologic agents are often effective to treat patients with cancer pain, but there are associated with serious side-effects and risks of dependence and addiction. The Thai Buddhism-based Mindfulness (TBbM) intervention created by a widely respected Buddhist monk focuses on testing a meditation technique to manage pain. If effective, millions of patients who suffer with cancer pain will benefit from use of a safe, culturally appropriate, non-pharmacologic approach to pain management.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness training program
  • Device: Cancer pain educational program
N/A

Detailed Description

Cancer is leading cause of death in Thailand. One hundred and twenty-eight men and 83 women per 100,000 had a common consequence both of malignancy and its treatment. Pain is experienced by 62% of Thai patients with cancer. Cancer pain is a major health problem because it causes both physical and psychological suffering for millions of individuals. Although pharmacological/analgesic treatment is effective, adverse side effects are common. Internationally, mindfulness is being used as an effective non-pharmacological treatment for psychological problems including distress, anxiety, stress, depression, and to improve quality of life in patients with cancer. However, the effect of mindfulness on pain as the primary outcome has not been sufficiently investigated. A few randomized controlled trials provide evidence that mindfulness interventions influence pain intensity in patients with cancer pain, but culturally targeted interventions have not been tested. Therefore, the purpose of this research is to test the effect of the Thai Buddhism-based Mindfulness (TBbM) program for pain management in Thai outpatients. Using a randomized controlled trial design, the investigators will test theTBbM intervention to improve pain in Thai outpatients (N=160) with cancer who are receiving cancer care at Sawanpracharak Hospital, Thailand. The control group (n = 80) will receive usual care and participate in a one-hour video educational program about cancer pain. The intervention group (n = 80) will receive usual care, participate in a one-hour video educational program about cancer pain, and receive an 8-week TBbM intervention. Investigators will accomplish the overall objective by pursuing the following three specific aims: 1) to compare the effect of the TBbM intervention to that of usual care on worst pain severity (primary outcome) as measured by the Brief Pain Inventory Thai Version (BPI-T); 2) to compare the effect of the TBbM intervention to that of usual care on secondary outcomes (i.e., pain interference, average pain, anxiety and depression, mindfulness, locus of control, and QoL) as measured by the BPI-T, the Hospital Anxiety and Depression Scale Thai Version (HADS-T), the Mindfulness Assessment Scale Thai Version (MAS-T), the Beliefs in Pain Control Questionnaire Thai Version (BPCQ-T) and the Functional Assessment of Cancer Therapy-General-Thai Version (FACT-G-T); and 3) to explore the mediating effects of TBbM-induced changes in cognitive (locus of control) and psychological factors (anxiety and depression) on worst pain severity. The investigators posit that the TBbM intervention will be more effective than usual care in reducing pain (primary outcome) and improving pain interference, anxiety, depression, mindfulness, locus of control, and QoL (secondary outcomes). T-tests, analysis of covariance (ANOVA), and path analysis approaches will be used to evaluate TBbM outcomes.

Study Design

Study Type:
Interventional
Actual Enrollment :
17 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Using a randomized controlled trial design, the investigators will test theTBbM intervention to improve pain in Thai outpatients (N=160) with cancer who are receiving cancer care at Sawanpracharak Hospital, Thailand. The control group (n = 80) will receive usual care and participate in a one-hour video educational program about cancer pain. The intervention group (n = 80) will receive usual care, participate in a one-hour video educational program about cancer pain, and receive an 8-week TBbM intervention.Using a randomized controlled trial design, the investigators will test theTBbM intervention to improve pain in Thai outpatients (N=160) with cancer who are receiving cancer care at Sawanpracharak Hospital, Thailand. The control group (n = 80) will receive usual care and participate in a one-hour video educational program about cancer pain. The intervention group (n = 80) will receive usual care, participate in a one-hour video educational program about cancer pain, and receive an 8-week TBbM intervention.
Masking:
Single (Participant)
Masking Description:
Eligible patients will 1) have any cancer type or stage, 2) be 18-60 years of age, 3) have a worst pain score > 4 in the past 7 days, 4) be able to read and write the Thai language, 5) have a Karnofsky Performance status > 70%, and be willing to travel to the temple. Exclusion criteria will be any diagnosed psychiatric illness that would prevent the patient from giving informed consent or from participating fully in the study. Patients with comorbidities (e.g., arthritis, bone metastasis, deformity, certain neurologic conditions such as biracial plexus nerve compression) that would impair the ability to perform the hand and arm movements also are ineligible.
Primary Purpose:
Treatment
Official Title:
Thai Buddhism-based Mindfulness for Pain Management in Thai Outpatients With Cancer: A Pilot Study
Actual Study Start Date :
May 23, 2018
Actual Primary Completion Date :
Feb 6, 2019
Actual Study Completion Date :
Mar 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness

Receiving education program and mindfulness training

Behavioral: Mindfulness training program
The mindfulness training program is a self-awareness mindfulness training program by performing the 15-position hand movement series

Device: Cancer pain educational program
A cancer pain education program by using Videos and personalized face-to-face techniques

Active Comparator: Control

Receiving education program

Device: Cancer pain educational program
A cancer pain education program by using Videos and personalized face-to-face techniques

Outcome Measures

Primary Outcome Measures

  1. Pain Change Over Time [Baseline, 4 weeks and 8 weeks]

    Worst pain scores are measured by Brief Pain Inventory. The Brief Pain Inventory-Short Form asks about pain in general, pain location, pain intensity (worst, least, average, and present), and is scored on a numerical rating scale of 0 (no pain) to 10 (pain as bad as one can imagine.

Secondary Outcome Measures

  1. Pain [Baseline and 8 weeks]

    Pain interference and average pain scores are measured by the Brief Pain Inventory

  2. Anxiety and depression [Baseline and 8 weeks]

    Anxiety and depression scores are measured by the Hospital Anxiety and Depression Scale

  3. Mindfulness [Baseline and 8 weeks]

    Mindfulness scores are measured by the Mindfulness Assessment Scale

  4. Locus of control [Baseline and 8 weeks]

    Personal control scores are measured by the Beliefs in Pain Control Questionnaire

  5. Quality of life [Baseline and 8 weeks]

    Quality of life scores are measured by the Functional Assessment of Cancer Therapy-General-Thai Version

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Eligible patients will:
  • have any cancer type or stage,

  • be 18-60 years of age,

  • have a worst pain score > 4 in the past 7 days,

  • be able to read and write the Thai language,

  • have a Karnofsky Performance status > 70%, and

  • be willing to travel to the temple.

Exclusion Criteria:
  • Patients will be diagnosed psychiatric illness

  • Patients will have the comorbidities (e.g., arthritis, bone metastasis, deformity, certain neurological conditions such as Brachial plexus nerve compression)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sawanpracharak Hospital Maung Nakhonsawan Thailand 60000

Sponsors and Collaborators

  • University of Michigan
  • Ministry of Health, Thailand

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Srisuda Ngamkham, Nursing Instructor, University of Michigan
ClinicalTrials.gov Identifier:
NCT03351010
Other Study ID Numbers:
  • 12/2561
First Posted:
Nov 22, 2017
Last Update Posted:
Mar 8, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Srisuda Ngamkham, Nursing Instructor, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2021